296 related articles for article (PubMed ID: 34619763)
1. A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene.
Magusali N; Graham AC; Piers TM; Panichnantakul P; Yaman U; Shoai M; Reynolds RH; Botia JA; Brookes KJ; Guetta-Baranes T; Bellou E; Bayram S; Sokolova D; Ryten M; Sala Frigerio C; Escott-Price V; Morgan K; Pocock JM; Hardy J; Salih DA
Brain; 2021 Dec; 144(12):3727-3741. PubMed ID: 34619763
[TBL] [Abstract][Full Text] [Related]
2. OAS1 rs1131454 genetic variant is associated with Alzheimer's disease: an epidemiological analysis.
Padhi S; Sarangi S; Nayak N; Pati A; Panda AK
Brain; 2022 Jun; 145(6):e61-e63. PubMed ID: 35383824
[No Abstract] [Full Text] [Related]
3. Single nucleotide variants in the
Chávez-Vélez E; Álvarez-Nava F; Torres-Vinueza A; Balarezo-Díaz T; Pilataxi K; Acosta-López C; Peña IZ; Narváez K
Front Cell Infect Microbiol; 2024; 14():1322882. PubMed ID: 38694517
[TBL] [Abstract][Full Text] [Related]
4. Multi-ancestry fine mapping implicates OAS1 splicing in risk of severe COVID-19.
Huffman JE; Butler-Laporte G; Khan A; Pairo-Castineira E; Drivas TG; Peloso GM; Nakanishi T; ; Ganna A; Verma A; Baillie JK; Kiryluk K; Richards JB; Zeberg H
Nat Genet; 2022 Feb; 54(2):125-127. PubMed ID: 35027740
[TBL] [Abstract][Full Text] [Related]
5. Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries.
Banday AR; Stanifer ML; Florez-Vargas O; Onabajo OO; Papenberg BW; Zahoor MA; Mirabello L; Ring TJ; Lee CH; Albert PS; Andreakos E; Arons E; Barsh G; Biesecker LG; Boyle DL; Brahier MS; Burnett-Hartman A; Carrington M; Chang E; Choe PG; Chisholm RL; Colli LM; Dalgard CL; Dude CM; Edberg J; Erdmann N; Feigelson HS; Fonseca BA; Firestein GS; Gehring AJ; Guo C; Ho M; Holland S; Hutchinson AA; Im H; Irby L; Ison MG; Joseph NT; Kim HB; Kreitman RJ; Korf BR; Lipkin SM; Mahgoub SM; Mohammed I; Paschoalini GL; Pacheco JA; Peluso MJ; Rader DJ; Redden DT; Ritchie MD; Rosenblum B; Ross ME; Anna HPS; Savage SA; Sharma S; Siouti E; Smith AK; Triantafyllia V; Vargas JM; Vargas JD; Verma A; Vij V; Wesemann DR; Yeager M; Yu X; Zhang Y; Boulant S; Chanock SJ; Feld JJ; Prokunina-Olsson L
Nat Genet; 2022 Aug; 54(8):1103-1116. PubMed ID: 35835913
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of the protective OAS1 rs10774671-G allele against severe COVID-19 in Moroccans: implications for a North African Neanderthal connection.
Yousfi FZE; Haroun AE; Nebhani C; Belayachi J; Askander O; Fahime EE; Fares H; Ennibi K; Abouqal R; Razine R; Bouhouche A
Arch Virol; 2024 Apr; 169(5):109. PubMed ID: 38658463
[TBL] [Abstract][Full Text] [Related]
7. 2'-5'-Oligoadenylate synthetase 1 polymorphisms are associated with tuberculosis: a case-control study.
Wu S; Wang Y; Chen G; Zhang M; Wang M; He JQ
BMC Pulm Med; 2018 Nov; 18(1):180. PubMed ID: 30497421
[TBL] [Abstract][Full Text] [Related]
8. [
Yaping LI; Song Z; Wenjun W; Huiling D; Mei LI; Xiaoli J; Shuangsuo D
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Apr; 39(4):381-386. PubMed ID: 31068279
[TBL] [Abstract][Full Text] [Related]
9. Association analysis of polymorphisms in OAS1 with susceptibility and severity of hand, foot and mouth disease.
Cai Y; Chen Q; Zhou W; Chu C; Ji W; Ding Y; Xu J; Ji Z; You H; Wang J
Int J Immunogenet; 2014 Oct; 41(5):384-92. PubMed ID: 25059424
[TBL] [Abstract][Full Text] [Related]
10. A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity.
Zhou S; Butler-Laporte G; Nakanishi T; Morrison DR; Afilalo J; Afilalo M; Laurent L; Pietzner M; Kerrison N; Zhao K; Brunet-Ratnasingham E; Henry D; Kimchi N; Afrasiabi Z; Rezk N; Bouab M; Petitjean L; Guzman C; Xue X; Tselios C; Vulesevic B; Adeleye O; Abdullah T; Almamlouk N; Chen Y; Chassé M; Durand M; Paterson C; Normark J; Frithiof R; Lipcsey M; Hultström M; Greenwood CMT; Zeberg H; Langenberg C; Thysell E; Pollak M; Mooser V; Forgetta V; Kaufmann DE; Richards JB
Nat Med; 2021 Apr; 27(4):659-667. PubMed ID: 33633408
[TBL] [Abstract][Full Text] [Related]
11. 2'-5' oligoadenylate synthetase 1 polymorphism is associated with prostate cancer.
Mandal S; Abebe F; Chaudhary J
Cancer; 2011 Dec; 117(24):5509-18. PubMed ID: 21638280
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial localization of the OAS1 p46 isoform associated with a common single nucleotide polymorphism.
Kjær KH; Pahus J; Hansen MF; Poulsen JB; Christensen EI; Justesen J; Martensen PM
BMC Cell Biol; 2014 Sep; 15():33. PubMed ID: 25205466
[TBL] [Abstract][Full Text] [Related]
13. OAS1 polymorphisms are associated with susceptibility to West Nile encephalitis in horses.
Rios JJ; Fleming JG; Bryant UK; Carter CN; Huber JC; Long MT; Spencer TE; Adelson DL
PLoS One; 2010 May; 5(5):e10537. PubMed ID: 20479874
[TBL] [Abstract][Full Text] [Related]
14. OAS1: a multiple sclerosis susceptibility gene that influences disease severity.
O'Brien M; Lonergan R; Costelloe L; O'Rourke K; Fletcher JM; Kinsella K; Sweeney C; Antonelli G; Mills KH; O'Farrelly C; Hutchinson M; Tubridy N
Neurology; 2010 Aug; 75(5):411-8. PubMed ID: 20679634
[TBL] [Abstract][Full Text] [Related]
15. Reassessment of the type I diabetes association of the OAS1 locus.
Qu HQ; Polychronakos C;
Genes Immun; 2009 Dec; 10 Suppl 1(Suppl 1):S69-73. PubMed ID: 19956105
[TBL] [Abstract][Full Text] [Related]
16. OAS1 gene, Spike protein variants and persistent COVID-19-related anosmia: may the olfactory disfunction be a harbinger of future neurodegenerative disease?
Di Stadio A; Bernitsas E; Ralli M; Severini C; Brenner MJ; Angelini C
Eur Rev Med Pharmacol Sci; 2022 Jan; 26(2):347-349. PubMed ID: 35113409
[No Abstract] [Full Text] [Related]
17. Single nucleotide polymorphism at exon 7 splice acceptor site of OAS1 gene determines response of hepatitis C virus patients to interferon therapy.
El Awady MK; Anany MA; Esmat G; Zayed N; Tabll AA; Helmy A; El Zayady AR; Abdalla MS; Sharada HM; El Raziky M; El Akel W; Abdalla S; Bader El Din NG
J Gastroenterol Hepatol; 2011 May; 26(5):843-50. PubMed ID: 21182542
[TBL] [Abstract][Full Text] [Related]
18. Identification of a Sjögren's syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons.
Li H; Reksten TR; Ice JA; Kelly JA; Adrianto I; Rasmussen A; Wang S; He B; Grundahl KM; Glenn SB; Miceli-Richard C; Bowman S; Lester S; Eriksson P; Eloranta ML; Brun JG; Gøransson LG; Harboe E; Guthridge JM; Kaufman KM; Kvarnström M; Cunninghame Graham DS; Patel K; Adler AJ; Farris AD; Brennan MT; Chodosh J; Gopalakrishnan R; Weisman MH; Venuturupalli S; Wallace DJ; Hefner KS; Houston GD; Huang AJW; Hughes PJ; Lewis DM; Radfar L; Vista ES; Edgar CE; Rohrer MD; Stone DU; Vyse TJ; Harley JB; Gaffney PM; James JA; Turner S; Alevizos I; Anaya JM; Rhodus NL; Segal BM; Montgomery CG; Scofield RH; Kovats S; Mariette X; Rönnblom L; Witte T; Rischmueller M; Wahren-Herlenius M; Omdal R; Jonsson R; Ng WF; ; Nordmark G; Lessard CJ; Sivils KL
PLoS Genet; 2017 Jun; 13(6):e1006820. PubMed ID: 28640813
[TBL] [Abstract][Full Text] [Related]
19. Association of SARS susceptibility with single nucleic acid polymorphisms of OAS1 and MxA genes: a case-control study.
He J; Feng D; de Vlas SJ; Wang H; Fontanet A; Zhang P; Plancoulaine S; Tang F; Zhan L; Yang H; Wang T; Richardus JH; Habbema JD; Cao W
BMC Infect Dis; 2006 Jul; 6():106. PubMed ID: 16824203
[TBL] [Abstract][Full Text] [Related]
20. Correlation of OAS1 gene polymorphism at exon 7 splice accepter site with interferon-based therapy of HCV infection in Pakistan.
Imran M; Manzoor S; Khattak NM; Tariq M; Khalid M; Javed F; Bhatti S
Viral Immunol; 2014 Apr; 27(3):105-11. PubMed ID: 24673406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
